Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
01 avr. 2024 06h00 HE
|
Fractyl Health, Inc.
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
Odysight.ai Announces 2023 Financial Results and Provides Corporate Update
27 mars 2024 08h30 HE
|
Odysight.ai Inc.
Revenues increased in more than 350% from its commercial contracts OMER, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive...
Thor Equities Group and Vesper Holdings Launch Student Housing Joint Venture
20 mars 2024 14h38 HE
|
Thor Equities Group
New York, NY, March 20, 2024 (GLOBE NEWSWIRE) -- Thor Equities Group and Vesper Holdings, leaders in real estate development and investment, are pleased to announce the launch of a joint venture...
Stephen Samuel Transforms Industries: From Premier Pharmacy Services to Evolve Realty & Development Corp.
18 mars 2024 17h27 HE
|
Evolve Realty & Development
BEVERLY HILLS, CA, March 18, 2024 (GLOBE NEWSWIRE) -- In a dynamic business world where adaptability and vision are the keys to lasting success, Stephen Samuel stands out as a transformative figure....
Veteran Entrepreneur Stephen Samuel to Spearhead Evolve Realty & Development Corp.
14 mars 2024 17h55 HE
|
Evolve Realty & Development
BEVERLY HILLS, CA, March 14, 2024 (GLOBE NEWSWIRE) -- After founding a niche pharmaceutical services company and building it into one of the largest sector players in the western United States,...
Osisko Development Secures US$50 Million Funding to Commence Underground Development at Cariboo Gold Project
04 mars 2024 07h05 HE
|
Osisko Development Corp.
MONTREAL, March 04, 2024 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") is pleased to announce the Company has entered into a credit...
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
04 mars 2024 02h00 HE
|
Medigene AG
Planegg/Martinsried, March 4, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid...
McEwen Mining: 2023 Year End and Q4 Results
29 févr. 2024 21h29 HE
|
McEwen Mining
TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) today reported its fourth quarter (“Q4”) and full year 2023 financial and operational results. Net income for the...
CAST and metafinanz join forces to advance Green IT initiatives
29 févr. 2024 09h00 HE
|
CAST
NEW YORK and PARIS, Feb. 29, 2024 (GLOBE NEWSWIRE) -- In a strategic advance toward enhancing IT sustainability, CAST and metafinanz, a consulting subsidiary of Allianz, have announced a partnership...
McEwen Mining 2023 Results Conference Call
28 févr. 2024 13h57 HE
|
McEwen Mining
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) invites you to join our conference call following the release of our Q4 and year-end 2023 financials results on...